Dr. Agarwal's Health Care Limited (NSE:AGARWALEYE)

Dr. Agarwal's Health Care Financials Overview

Financials in millions INR. Fiscal year is April - March.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Revenue Revenue Growth	23,583	20,801	17,110	13,322	10,180	6,961
Revenue Growth	25.64%	21.57%	28.44%	30.86%	46.25%	47.73%
Gross Profit Gross Profit Growth	10,243	8,997	7,244	5,658	4,321	2,936
Operating Income Operating Income Growth	3,401	2,932	2,300	1,919	1,441	846.92
Net Income Net Income Growth	1,698	1,332	834.6	830.6	940.97	376.94
Earnings Per Share EPS Growth	5.31	4.18	2.78	3.13	4.00	1.83
EPS Growth	46.36%	50.36%	-11.18%	-21.75%	118.58%	-

Revenue by Geography

Chart

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
India India Growth	18,707	15,376	11,618	8,734	5,635
outside India outside India Growth	2,094	1,734	1,704	1,446	1,326
Total Total Growth	20,801	17,110	13,322	10,180	6,961

Cash & Debt

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Investments Cash & Investments Growth	1,714	2,838	5,147	5,823	1,606	996.21
Total Debt Total Debt Growth	11,818	10,662	9,609	9,665	8,573	6,333
Net Cash (Debt) Net Cash Growth	-10,103	-7,824	-4,463	-3,843	-6,967	-5,337
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share Net Cash Per Share Growth	-31.60	-24.58	-14.88	-14.49	-29.55	-25.93

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Cash Flow Operating Cash Flow Growth	5,373	5,190	3,571	3,460	2,331	1,643
Capital Expenditures CapEx Growth	-4,924	-4,480	-3,087	-2,309	-1,566	-702.39
Free Cash Flow Free Cash Flow Growth	448.8	710.4	484.8	1,151	765.33	940.89
Free Cash Flow Growth	71.95%	46.53%	-57.88%	50.38%	-18.66%	-

Margins

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Gross Margin	43.43%	43.25%	42.34%	42.48%	42.45%	42.18%
Operating Margin	14.42%	14.10%	13.44%	14.41%	14.15%	12.17%
Pretax Margin	12.57%	11.95%	9.34%	10.55%	8.21%	8.15%
Profit Margin	7.20%	6.40%	4.88%	6.24%	9.24%	5.42%
FCF Margin	1.90%	3.42%	2.83%	8.64%	7.52%	13.52%

Valuation

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 9, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	98.12	96.70	168.75	-	-	-
Forward PE	68.77	76.32	121.98	-	-	-
P/FCF Ratio	364.50	181.30	290.50	-	-	-
PS Ratio	6.94	6.19	8.23	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Nov 5, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 9, 2026

Data Sources Report a data error